HPE Europe is back!
Join the biggest names in healthcare, life sciences and private equity for an unforgettable day of thought-provoking discussions, cutting-edge insights and valuable networking opportunities at the...more
8/16/2023
/ Artificial Intelligence ,
Digital Health ,
Events ,
Health Care Providers ,
Health Information Technologies ,
Health Technology ,
Healthcare Facilities ,
Investment Banks ,
Investment Opportunities ,
Investors ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds
Key Trends & Opportunities in Life Sciences and Healthcare Investing -
The current macroeconomic environment is creating challenges for healthcare and life sciences businesses, which have been impacted hard by wage...more
12/9/2022
/ Capital Markets ,
Digital Health ,
EU ,
Healthcare ,
Investment ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Private Equity ,
Technology ,
UK
This wide ranging discussion, sponsored by our Paris office, focuses on navigating cross border collaborations, insights for entering the US life sciences market as well as strategies for capitalizing on the growth of digital...more
Today’s global healthcare marketplace is marked by unprecedented transformation. The seismic shifts in healthcare delivery and drug development during COVID-19 have, in 2021, continued to demonstrate the power and capacity...more
9/20/2021
/ Austria ,
Cannabis Products ,
Clinical Trials ,
Coronavirus/COVID-19 ,
Data Protection ,
Denmark ,
Digital Health ,
EU ,
France ,
Germany ,
Healthcare ,
Information Technology ,
Investment ,
Italy ,
Medical Devices ,
Netherlands ,
Pharmaceutical Industry ,
Poland ,
Procurement Guidelines ,
Proposed Legislation ,
Spain ,
Supply Chain ,
Switzerland ,
Telemedicine ,
UK ,
UK Brexit ,
Whistleblowers
McDermott was delighted to partner with the BVCA (British Venture Capital Association) on its recent virtual Sector Forum Series: Healthcare event. The event gathered industry experts – from entrepreneurs, to investors and...more
12/3/2020
/ Capital Markets ,
Digital Health ,
Entrepreneurs ,
EU ,
Healthcare ,
Investment ,
Investment Adviser ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Private Equity ,
UK ,
Venture Capital
In light of the COVID-19 pandemic, the third annual European Healthcare Private Equity Symposium will be conducted as a five-part webinar series, taking place over five weeks in a virtual tour across several European...more
6/30/2020
/ Coronavirus/COVID-19 ,
Digital Health ,
Health Care Providers ,
Health Technology ,
Industry Consolidation ,
Innovation ,
Investment Opportunities ,
Investors ,
Life Sciences ,
Physicians ,
Private Equity ,
Private Equity Firms ,
Webinars
Across the US and EU, life sciences companies are pushing diagnostics, antibody testing, vaccines and other efforts forward to flatten the Coronavirus (COVID-19) curve. Our multidisciplinary cross-border life sciences team...more
5/5/2020
/ Acquisitions ,
Contact Tracing ,
Coronavirus/COVID-19 ,
Cross-Border Transactions ,
Diagnostic Tests ,
Digital Health ,
Divestiture ,
Due Diligence ,
Foreign Investment ,
Health Care Providers ,
Intellectual Property Protection ,
Joint Venture ,
Life Sciences ,
Medical Testing ,
Mergers ,
Partnerships ,
Pharmaceutical Industry ,
Regulatory Oversight ,
Vaccinations ,
Virus Testing ,
Webinars
From the rise of digital health opportunities to concerns stemming from political shifts, McDermott partners review major European health trends in 2019 and look forward to what we might expect to see from 2020 onwards....more
A recent McDermott round table on European health private equity generated key insights into the future of medtech, digital health, and data analytics, and identified opportunities for companies and investors.
Digital...more
12/20/2019
/ CFIUS ,
Digital Health ,
Digital Services Tax ,
Global Dealmaking ,
Healthcare ,
International Arbitration ,
Life Sciences ,
Medical Devices ,
Outbound Transactions ,
Private Equity ,
State-Owned Enterprises ,
UK Competition and Markets Authority (CMA)
The MDR and other recent developments in the health care regulatory landscape pose new opportunities and challenges for medical software companies and investors in digital health in the United Kingdom. Although the regulatory...more
7/3/2019
/ Biotechnology ,
Certification Requirements ,
Code of Conduct ,
Digital Health ,
EU ,
Innovation ,
Life Sciences ,
Manufacturers ,
Medical Devices ,
Member State ,
New Regulations ,
No-Deal Brexit ,
Regulatory Oversight ,
UK
Introduction -
The past year was an active one for data privacy and security legislation and enforcement. Protection for certain personal data was enhanced internationally by the EU General Data Protection Regulation...more
1/29/2019
/ Biometric Information ,
Biometric Information Privacy Act ,
California Consumer Privacy Act (CCPA) ,
Cybersecurity ,
Data Protection ,
Digital Health ,
Electronic Protected Health Information (ePHI) ,
EU ,
General Data Protection Regulation (GDPR) ,
Health Care Providers ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Personally Identifiable Information ,
State Data Breach Notification Statutes ,
UK